Internal Medicine, Infectious Disease · Fresno, CA
NPI
1396191987
Since 2016
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2335 E Kashian Ln Ste 280
Fresno, CA, 93701
Phone (559) 320-1090
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,080 services
Medicare patients, 2024
279
Average age 72
Drug cost, 2024
$661K
629 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirisha Pasula was code 99232 (hospital e&m - subsequent), 623 times for 211 patients. In total Shirisha Pasula billed 1,080 services in 14 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 623 | 211 | $59.52 | $37K |
| 99233 Hospital E&M - Subsequent | Facility | 147 | 72 | $90.02 | $13K |
| 99223 Hospital E&M - Initial | Facility | 128 | 112 | $130.78 | $17K |
| 99222 Hospital E&M - Initial | Facility | 107 | 98 | $95.48 | $10K |
| 99231 Hospital E&M - Subsequent | Facility | 28 | 23 | $37.39 | $1,047 |
| 99213 Office E&M - Established | Office | 15 | 13 | $59.65 | $895 |
By year: 2022 $88K for 1,171 services; 2023 $98K for 1,271 services; 2024 $81K for 1,080 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirisha Pasula prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 51 prescriptions and refills. In total Shirisha Pasula wrote 629 Medicare prescriptions that cost $661K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 51 | 51 | Under 11 | $196K |
| Vancomycin Hcl Generic | 42 | 42 | 12 | $9,487 |
| Levofloxacin Generic | 35 | 35 | 33 | $125 |
| Tivicay Dolutegravir Sodium | 35 | 35 | Under 11 | $79K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 20 | $839 |
| Descovy Emtricitabine/Tenofov Alafenam | 25 | 25 | Under 11 | $54K |
| Cephalexin Generic | 24 | 34 | 12 | $211 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 27 | 13 | $191 |
| Ertapenem Ertapenem Sodium | 22 | 22 | Under 11 | $10K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 21 | 21 | Under 11 | $4,781 |
| Cefdinir Generic | 20 | 20 | 19 | $217 |
| Avycaz Ceftazidime/Avibactam | 18 | 18 | Under 11 | $138K |
| Doxycycline Hyclate Generic | 16 | 20 | Under 11 | $343 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 15 | 15 | Under 11 | $1,201 |
| Cefazolin Sodium Generic | 14 | 14 | Under 11 | $720 |
Brand drugs: 196 claims; generic drugs: 433 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirisha Pasula $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.